Literature DB >> 974056

Abnormal pupillary responses in myasthenia gravis. A pupillographic study.

A Yamazaki, S Ishikawa.   

Abstract

Using an open-loop stimulus (Maxwellian view), the direct pupillary response to light and its derivative curves (velocity and accleration of pupillary reactions) were recorded by infrared video pupillography in seven patients with myasthenia gravis and in three normal subjects. Responses before and after intravenous injection of 5 mg edrophonium hydrochloride were determined. Five of the patients had never taken anticholinesterase drugs except for diagnostic injections of edrophonium while the other two patients had been treated with oral preparations of corticosteroids. Analyses of the pupillary responses showed reduced amplitude, amximal velocity, and maximal acceleration of pupillary constriction in the myasthenic patients. On the other hand, changes in parameters of pupillary dilatation were minimal. Abnormal values returned towards normal within five minutes after edrophonium injection in all patients except in one individual who was being treated with corticosteroids at the time of examination. These results suggest that involvement of the iris sphincter may be common in patients with myasthenia gravis and this can be demonstrated by analysing the pupillary reaction and its derivative curves in response to an open-loop stimulus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974056      PMCID: PMC1042752          DOI: 10.1136/bjo.60.8.575

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Blockade of acetylcholine receptors: a model of myasthenia gravis.

Authors:  S Satyamurti; D B Drachman; F Slone
Journal:  Science       Date:  1975-03-14       Impact factor: 47.728

2.  DEFECTS OF NEAR VISION IN MYASTHENIA GRAVIS.

Authors:  N MANSON; G STERN
Journal:  Lancet       Date:  1965-05-01       Impact factor: 79.321

3.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

4.  ERG in human eyes following oral adrenocorticoids.

Authors:  T J Zimmerman; W W Dawson; C R Fitzgerald
Journal:  Invest Ophthalmol       Date:  1973-10

5.  Speed of pupillary light response following topical pilocarpine or tropicamide.

Authors:  S S Morgan; R W Hollenhorst; K N Ogle
Journal:  Am J Ophthalmol       Date:  1968-11       Impact factor: 5.258

6.  A new videopupillography.

Authors:  S Ishikawa; M Naito; K Inaba
Journal:  Ophthalmologica       Date:  1970       Impact factor: 3.250

7.  Derivative curve in evaluation of pupillary reflex response to light.

Authors:  M E Meyer; K N Ogle; R W Hollenhorst; N J Moyer
Journal:  Exp Eye Res       Date:  1969-07       Impact factor: 3.467

8.  Internal 'ophthalmoplegia' in myasthenia gravis.

Authors:  Y Herishanu; S Lavy
Journal:  Ophthalmologica       Date:  1971       Impact factor: 3.250

  8 in total
  5 in total

1.  Sensitivity of nasal and temporal hemiretinas in latent nystagmus and strabismus evaluated using the light reflex.

Authors:  H Sekiya; S Hasegawa; K Mukuno; S Ishikawa
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

2.  The ocular signs and symptoms of myasthenia gravis.

Authors:  H J Oosterhuis
Journal:  Doc Ophthalmol       Date:  1982-01-29       Impact factor: 2.379

3.  Dysfunction of the pupillary light reflex in experimental autoimmune autonomic ganglionopathy.

Authors:  Shalini Mukherjee; Steven Vernino
Journal:  Auton Neurosci       Date:  2007-07-05       Impact factor: 3.145

Review 4.  Ocular myasthenia gravis: a review.

Authors:  Akshay Gopinathan Nair; Preeti Patil-Chhablani; Devendra V Venkatramani; Rashmin Anilkumar Gandhi
Journal:  Indian J Ophthalmol       Date:  2014-10       Impact factor: 1.848

5.  The Spectrum of Autonomic Dysfunction in Myasthenic Crisis.

Authors:  Rohit Ninan Benjamin; Sanjith Aaron; Ajith Sivadasan; Suresh Devasahayam; Amalan Sebastin; Mathew Alexander
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.